We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA SHOULD TEST DIFFERENT METHODS FOR DTC ADS, FTC SAYS
FDA SHOULD TEST DIFFERENT METHODS FOR DTC ADS, FTC SAYS
May 18, 2004
The FDA should test different models of the brief summaries drugmakers are required to include in their direct-to-consumer advertising in order to see which version consumers would be more likely to read and understand, the Federal Trade Commission (FTC) says.